Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life

NCT01141933 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 513

Last updated 2018-03-06

No results posted yet for this study

Summary

The purpose of this study is to test the efficacy of a cognitive-existential intervention (using either an individual or a group format) to improve the existential and global quality of life of patients as compared to usual care in a population of adult non-metastatic cancer patients.

Conditions

  • Non-metastatic Cancer
  • Adjustment Disorder

Interventions

OTHER

Cognitive-existential intervention

Over the past 2 years we developed a 12-week cognitive-existential intervention consisting of 12 modules. The first three modules essentially involve cognitive and behavioral techniques proposing reinforcement of the use of active behavioral (e.g., relaxation, activation) and emotional (cognitive reframing) strategies. This content comes from classical cognitive-behavioral techniques. The next 3 modules, inspired by empirically-tested interventions further explore emotional strategies. The last six modules specifically address the existential dimension. They are adapted from logotherapy techniques, which are also empirically-based, and have been adapted to a French-Canadian culture by our team. They aim to improve meaning-based and emotional coping strategies.

OTHER

Usual care

This group receive the usual treatment only.

Sponsors & Collaborators

  • Laval University

    collaborator OTHER
  • Centre de recherche en cancérologie de l'Université Laval

    collaborator UNKNOWN
  • Canadian Cancer Society (CCS)

    collaborator OTHER
  • Maison Michel-Sarrazin

    collaborator UNKNOWN
  • CHU de Quebec-Universite Laval

    lead OTHER

Principal Investigators

  • Pierre Gagnon, MD, FRCPC · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-12-31
Completion
2018-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01141933 on ClinicalTrials.gov